MidFirst Bank’s DexCom DXCM Stock Holding History

MidFirst Bank’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.57K	Buy	53 +17	+47%	+$1.13K	﹤0.01%	626
2026 Q1	$2.26K	Buy	+36	New	+$2.51K	﹤0.01%	669

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MidFirst Bank's DXCM Position: Q2 2026 in Review

MidFirst Bank increased its DexCom (DXCM) stake by 47% in Q2 2026, buying an estimated $1.13K and bringing the position to 53 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

MidFirst Bank first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 975 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

MidFirst Bank held 53 shares of DexCom worth $3.57K as of Q2 2026.
MidFirst Bank bought 17 DexCom shares in Q2 2026, an estimated $1.13K.
DexCom made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #626 holding.
MidFirst Bank first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
975 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.